NCT00780624

Nasal Intermittent Positive Pressure Ventilation In Newborn Infants With Respiratory Distress Syndrome

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Third Military Medical University · Academic / Other
• Sex: All
• Age: 1 Minute – 28 Days
• Healthy volunteers: Not accepted

Summary

The submitted trial is the first prospective, randomized trial comparing nasal intermittent positive pressure ventilation(NIPPV) vs nCPAP in newborn infants with respiratory distress syndrome.

Detailed description

Nasal intermittent positive pressure ventilation (NIPPV) is similar to nCPAP, but also gives some breaths, or extra support, to newborn infants through a small tube in the nose. NIPPV is safe and effective, and already in use as an alternate "standard" therapy. Nevertheless, NIPPV has never been used in chinese babies. The submitted trial is the first prospective, randomized trial Comparing NIPPV vs nCPAP in newborn infants with respiratory distress syndrome.

Conditions

• Respiratory Distress Syndrome

Interventions

Type	Name	Description
DEVICE	NIPPV	Ventilator is Bird VIP.
DEVICE	NIPPV	Ventilator(Bird VIP) is used for NIPPV device. Non-invasive NIPPV is used in the NIPPV group instead of nCPAP in the control group.
DEVICE	NIPPV	Ventilator (Bird VIP, USA) is used for provide of NIPPV in the NIPPV group instead of nCPAP in the control group. The duration of NIPPV is according to the baby's respiratory condition.

Timeline

• Start date: 2008-01-01
• Primary completion: 2011-12-01
• Completion: 2012-12-01
• First posted: 2008-10-27
• Last updated: 2016-04-21

Locations

1 site across 1 country: China